These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

94 related items for PubMed ID: 15693804

  • 1. IL-10 promoter haplotype influence on interferon treatment response in multiple sclerosis.
    Wergeland S, Beiske A, Nyland H, Hovdal H, Jensen D, Larsen JP, Marøy TH, Smievoll AI, Vedeler CA, Myhr KM.
    Eur J Neurol; 2005 Mar; 12(3):171-5. PubMed ID: 15693804
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Proximal interleukin-10 gene polymorphisms in Italian patients with systemic sclerosis.
    Beretta L, Cappiello F, Barili M, Scorza R.
    Tissue Antigens; 2007 Apr; 69(4):305-12. PubMed ID: 17389013
    [Abstract] [Full Text] [Related]

  • 4. Interleukin-10 promoter polymorphism predicts initial response of chronic hepatitis C to interferon alfa.
    Edwards-Smith CJ, Jonsson JR, Purdie DM, Bansal A, Shorthouse C, Powell EE.
    Hepatology; 1999 Aug; 30(2):526-30. PubMed ID: 10421663
    [Abstract] [Full Text] [Related]

  • 5. Interleukin 10 promoter haplotype is associated with alcoholic liver cirrhosis in Taiwanese patients.
    Yang AM, Wen LL, Yang CS, Wang SC, Chen CS, Bair MJ.
    Kaohsiung J Med Sci; 2014 Jun; 30(6):291-8. PubMed ID: 24835349
    [Abstract] [Full Text] [Related]

  • 6. The interleukin-10 promoter haplotype ATA is a putative risk factor for aggressive periodontitis.
    Reichert S, Machulla HK, Klapproth J, Zimmermann U, Reichert Y, Gläser CH, Schaller HG, Stein J, Schulz S.
    J Periodontal Res; 2008 Feb; 43(1):40-7. PubMed ID: 18230105
    [Abstract] [Full Text] [Related]

  • 7. Interleukin-10 promoter polymorphisms in myasthenia gravis.
    Alseth EH, Nakkestad HL, Aarseth J, Gilhus NE, Skeie GO.
    J Neuroimmunol; 2009 May 29; 210(1-2):63-6. PubMed ID: 19299022
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Heterogeneity in response to interferon beta in patients with multiple sclerosis: a 3-year monthly imaging study.
    Chiu AW, Richert N, Ehrmantraut M, Ohayon J, Gupta S, Bomboi G, Gaindh D, Cantor FK, Frank JA, McFarland HF, Bagnato F.
    Arch Neurol; 2009 Jan 29; 66(1):39-43. PubMed ID: 19001157
    [Abstract] [Full Text] [Related]

  • 10. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus.
    Lazarus M, Hajeer AH, Turner D, Sinnott P, Worthington J, Ollier WE, Hutchinson IV.
    J Rheumatol; 1997 Dec 29; 24(12):2314-7. PubMed ID: 9415634
    [Abstract] [Full Text] [Related]

  • 11. Chemokine receptor CCR5 in interferon-treated multiple sclerosis.
    Sellebjerg F, Kristiansen TB, Wittenhagen P, Garred P, Eugen-Olsen J, Frederiksen JL, Sørensen TL.
    Acta Neurol Scand; 2007 Jun 29; 115(6):413-8. PubMed ID: 17511851
    [Abstract] [Full Text] [Related]

  • 12. Interleukin-10 [ATA] promoter haplotype and prostate cancer risk: a population-based study.
    Eder T, Mayer R, Langsenlehner U, Renner W, Krippl P, Wascher TC, Pummer K, Kapp KS.
    Eur J Cancer; 2007 Feb 29; 43(3):472-5. PubMed ID: 17182240
    [Abstract] [Full Text] [Related]

  • 13. Frequency distribution of interleukin-10 haplotypes (-1082 A>G, -819 C>T, and -592 C>A) in a Mexican population.
    Vázquez-Villamar M, Palafox-Sánchez CA, Hernández-Bello J, Muñoz-Valle JF, Valle Y, Cruz A, Alatorre-Meza AI, Oregon-Romero E.
    Genet Mol Res; 2016 Nov 03; 15(4):. PubMed ID: 27819740
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Interleukin-10 promoter polymorphisms in patients with multiple sclerosis.
    Myhr KM, Vågnes KS, Marøy TH, Aarseth JH, Nyland HI, Vedeler CA.
    J Neurol Sci; 2002 Oct 15; 202(1-2):93-7. PubMed ID: 12220699
    [Abstract] [Full Text] [Related]

  • 16. Interleukin-10 promoter polymorphism is associated with the predisposition to the development of IgA nephropathy and focal segmental glomerulosclerosis in Korea.
    Chin HJ, Na KY, Kim SJ, Oh KH, Kim YS, Lim CS, Kim S, Chae DW.
    J Korean Med Sci; 2005 Dec 15; 20(6):989-93. PubMed ID: 16361810
    [Abstract] [Full Text] [Related]

  • 17. Association of interleukin-(IL)10 haplotypes and serum IL-10 levels in the progression of childhood immune thrombocytopenic purpura.
    Tesse R, Del Vecchio GC, De Mattia D, Sangerardi M, Valente F, Giordano P.
    Gene; 2012 Aug 15; 505(1):53-6. PubMed ID: 22677268
    [Abstract] [Full Text] [Related]

  • 18. Interleukin-10 promoter polymorphism in multiple sclerosis: association with disease progression.
    Almeras L, Meresse B, Seze J, De Lefranc D, Dubucquoi S, Fajardy I, Vermersch P, Prin L.
    Eur Cytokine Netw; 2002 Aug 15; 13(2):200-6. PubMed ID: 12101075
    [Abstract] [Full Text] [Related]

  • 19. Interleukin-10 promoter polymorphisms and the outcome of hepatitis C virus infection.
    Knapp S, Hennig BJ, Frodsham AJ, Zhang L, Hellier S, Wright M, Goldin R, Hill AV, Thomas HC, Thursz MR.
    Immunogenetics; 2003 Sep 15; 55(6):362-9. PubMed ID: 12942209
    [Abstract] [Full Text] [Related]

  • 20. Interleukin 7 receptor alpha chain haplotypes vary in their influence on multiple sclerosis susceptibility and response to interferon Beta.
    Hoe E, McKay F, Schibeci S, Heard R, Stewart G, Booth D.
    J Interferon Cytokine Res; 2010 May 15; 30(5):291-8. PubMed ID: 20187771
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.